Screening for Blunt Cerebrovascular Injuries is Cost-Effective

Abstract

From the societal perspective, CTA is the most cost-effective screening strategy for patients at high risk for BCVI. From an institutional perspective, CTA prevents the most strokes at a reasonable cost.